GlassScriptPhysician profile
Ahmed Elfiky
NPI 1568551075
$8,995.52
in general payments reported to CMS, 2019-2025
42 companies · $3,136 in 2025
The $3,136 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $829 · 2021: $1,319 · 2022: $824 · 2023: $919 · 2024: $1,394 · 2025: $3,136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,074 · Travel and Lodging: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,073.86 |
| Travel and Lodging | $1,375.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,049.57 | 2024-2025 | Spyglass, General - Therapies, Exalt Model D |
| Biogen, INC. | $1,644.38 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Scilex Pharmaceuticals INC. | $1,270.67 | 2019-2025 | Ztlido |
| Abbvie INC. | $703.48 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $421.04 | 2020-2025 | |
| Harmony Biosciences LLC | $418.36 | 2020-2025 | Wakix |
| Pfizer INC. | $396.18 | 2022-2025 | |
| Horizon Therapeutics Plc | $213.00 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $173.22 | 2020-2021 | |
| Sk Life Science, INC. | $160.20 | 2021 | |
| Allergan, INC. | $147.55 | 2020 | |
| Genzyme Corporation | $135.66 | 2020-2022 | |
| Argenx US, INC. | $134.12 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Supernus Pharmaceuticals, INC. | $106.12 | 2019-2022 | |
| Ucb, INC. | $95.53 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Elfiky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.